Cargando…
ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression
Prostate cancer is still one of the most common malignancies in men all around the world. The mechanism of how prostate cancer initiates and develops is still not clear. Here in this study, we show that tumor suppressor ZBTB38 could suppress the migration and proliferation of prostate cancer cells....
Autores principales: | Ding, Guanxiong, Lu, Wei, Zhang, Qing, Li, Kai, Zhou, Huihui, Wang, Fei, Zhao, Chunchun, Fan, Caibin, Wang, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546125/ https://www.ncbi.nlm.nih.gov/pubmed/34697293 http://dx.doi.org/10.1038/s41419-021-04278-3 |
Ejemplares similares
-
HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer
por: Lu, Wei, et al.
Publicado: (2020) -
HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer
por: Wang, Jianqing, et al.
Publicado: (2019) -
Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer
por: Sun, Jian, et al.
Publicado: (2022) -
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer
por: de Dieuleveult, Maud, et al.
Publicado: (2020) -
ZBTB38 is dispensable for antibody responses
por: Wong, Rachel, et al.
Publicado: (2020)